Hedge fund manager Cathie Wood has doubled down on shares of Coinbase (COIN) amid the tariff-induced stock market correction.

The ARKK fund bought 69,011 shares of CRISPR Therapeutics AG and 142,713 shares of Beam Therapeutics Inc. Based on the last ...

Cathie Wood, CEO of Ark Investment Management, typically focuses on small- and mid-cap technology stocks. She sometimes ventures into megacap stocks, likely aiming to add stability to her funds. That ...

According to ARK’s daily trading disclosure for April 4, Wood’s flagship ARK Innovation ETF (ARKK) bought nearly 55,000 ...

Cathie Wood’s trades often signal market sentiment, influencing stock momentum and attracting investor interest. Wood Offloads META Stock The highlight of the day was ARK Innovation Fund (ARKK ...

Ark Invest CEO Cathie Wood, one of the earliest traditional financial investors in crypto, hopes to bring some of her company’s funds on-chain once the regulatory landscape allows companies in ...

Cathie Wood, the head of Ark Investment ... She bought $12 million shares of a Chinese tech stock. Wood’s flagship fund, the Ark Innovation ETF (ARKK) , is down 17.41% year-to-date as of March ...

21:31 EDT Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics (BEAM) today Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top ...

Ark Investment Management, led by Cathie Wood, is moving the primary listings of three of its innovation exchange-traded funds to the Cboe BZX Exchange from NYSE Arca, it said on Thursday.